A compound for breast cancer discovered and developed in the Hergenrother and Shapiro labs has been licensed to Bayer

Paul Hergenrother helps discover cancer compound now in licensing deal. Researchers affiliated with the Cancer Center at Illinois discovered a novel small molecule compound that is now the subject of a new global licensing agreement between the pharmaceutical company Bayer AG and the cancer drug development company Systems Oncology LLC.

Read the entire LAS story here.